中国医药导报
中国医药期刊欢迎您 今天是   2025年4月6日星期天
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  论著 本期目录 | 过刊浏览 | 高级检索 |
维生素D干预对支气管哮喘幼鼠外周血T淋巴细胞平衡调节及肠道菌群的影响
蔡姿秀1  周国华1  田军2▲
1.杭州市萧山区第一人民医院儿科,浙江杭州   311200;
2.杭州市萧山区第三人民医院儿科,浙江杭州   311256
Effects of vitamin D intervention on balance regulation of peripheral blood T lymphocytes and intestinal flora in young rats with bronchial asthma
CAI Zixiu1   ZHOU Guohua1   TIAN Jun2▲
1.Department of Pediatrics, the First People’s Hospital of Xiaoshan District, Hangzhou City, Zhejiang Province, Hangzhou   311200, China; 
2.Department of Pediatrics, the Third People’s Hospital of Xiaoshan District, Hangzhou City, Zhejiang Province, Hangzhou   311256, China
全文: PDF (1753 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 研究维生素D(VitD)干预对支气管哮喘(以下简称“哮喘”)幼鼠外周血T淋巴细胞平衡调节及肠道菌群的影响。 方法 选取30只7 d龄SPF级野生型BALB/c雌性小鼠(体重4.09~6.13 g)为研究对象,采用随机数字表法将其分为哮喘模型组(15只)和VitD干预组(15只),另选取10只为健康对照组。实验第1、7天,哮喘模型组及VitD干预组采用10%卵清蛋白(OVA)致敏液200 μl腹腔注射,健康对照组注射等量生理盐水。第18天,VitD干预组给予VitD滴剂[35 μg/(kg·周),1次/2 d]灌胃,共给药2周,健康对照组、哮喘模型组灌胃等量磷酸盐缓冲液。第19天,哮喘模型组和VitD干预组给予3%OVA溶液10 ml雾化吸入20 min,健康对照组给予等量生理盐水雾化吸入,1次/d,共6 d。实验结束后,观察三组肺组织切片苏木精-伊红染色结果;采用流式细胞仪检测并计算三组血清Th1/Th2、Th17/调节性T细胞(Treg)比值;通过16S rDNA测序法分析三组粪便内菌群情况。 结果 健康对照组肺组织支气管壁及肺泡壁结构完整,肺泡腔内无渗出,肺泡上皮排列有序,肺泡壁厚度正常;哮喘模型组肺泡壁结构受损,肺泡上皮细胞破坏,黏膜充血水肿,血管周围炎症细胞浸润;VitD干预组肺组织炎症反应较轻。三组测序样本微生物物种Shannon指数曲线趋平缓,三组Simpson指数比较,差异无统计学意义(P>0.05)。PCoA图分析显示,哮喘模型组和健康对照组组间距离大,VitD干预组与哮喘模型组组间距离近(P<0.05)。三组肠道菌群涉及15个门,23个属。哮喘模型组Th1/Th2比值及Actinobacteriota、Helicobacter、Colidextribacter丰度低于健康对照组,Th17/Treg比值及Proteobacteria、Ligilactobacillus、Bacteroides丰度高于健康对照组(P<0.05)。VitD干预组Thl/Th2比值及Actinobacteriota、Proteobacteria、Helicobacter、Colidextribacter丰度高于哮喘模型组,Th17/Treg比值及Ligilactobacillus、Bacteroides丰度低于哮喘模型组(P<0.05),与基于属水平的Heatmap分析结果一致。 结论 VitD干预可以调节外周血T淋巴细胞的平衡,改变哮喘幼鼠的肠道菌群,可能是该病发病机制的新切入点。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
蔡姿秀1  周国华1  田军2▲
关键词 维生素D支气管哮喘肠道菌群外周血T淋巴细胞平衡调节机制
    
Abstract:Objective To investigate the effects of vitamin D (VitD) intervention on the balance regulation of peripheral blood T lymphocytes and intestinal flora in young rats with bronchial asthma (hereinafter referred to as “asthma”). Methods Thirty SPF wild-type BALB/c female mice (4.09 - 6.13 g) aged seven days were selected as the study objects, and they were divided into asthma model group (15 rats) and VitD intervention group (15 rats) by random number table method, another ten rats were selected as healthy control group. On the first and seventh day of the experiment, asthma model group and VitD intervention group were injected intraperitoneally with 10% ovalbumin (OVA) sensitizing solution 200 μl, while healthy control group was injected with the same amount of normal saline. On the 18th day, VitD intervention group was given VitD drops (35 μg/kg, per week, one every two days) for two weeks, and healthy control group and asthma model group were given the same amount of phosphate buffer. On the 19th day, asthma model group and VitD intervention group were given atomized inhalation of 3%OVA solution 10 ml for 20 min, while healthy control group was given atomized inhalation of normal saline, once a day for six days. After the experiment, the hematoxylin-eosin staining results of lung tissue sections in three groups were observed. Serum Th1/Th2 and Th17/ regulatory T cell (Treg) ratios were measured and calculated by flow cytometry. The bacterial community in feces of the three groups was analyzed by 16S rDNA sequencing method. Results In the healthy control group, the structure of the bronchial wall and alveolar wall of the lung tissue were complete, there was no exudation in the alveolar cavity, the alveolar epithelium was orderly, and the alveolar wall thickness was normal. In asthmatic model group, the structure of alveolar wall was damaged, alveolar epithelial cells were destroyed, mucosal hyperemia and edema were observed, and perivascular inflammatory cells were infiltrated. The inflammatory reaction of lung tissue in VitD intervention group was less. The Shannon index curve of microbial species in the three groups was flat, and there was no statistical significance in Simpson index among the three groups (P>0.05). PCoA diagram analysis showed that the distance between the asthma model group and the healthy control group was large, and the distance between the VitD intervention group and the asthma model group was close (P<0.05). The three groups of intestinal flora involved 15 divisions and 23 genera. Th1/Th2 ratio and the abundance of Actinobacteriota, Helicobacter, and  Colidextribacter in asthma model group were lower than those in healthy control group, Th17/Treg ratio and the abundance of Proteobacteria, Ligilactobacillus, and  Bacteroides of asthma model group were higher than those of healthy control group (P<0.05). Th1/Th2 ratio and the abundance of Actinobacteriota, Proteobacteria, Helicobacter, and Colidextribacter in VitD intervention group were higher than those in asthma model group, The Th17/Treg ratio and the abundance of Ligilactobacillus, Bacteroides in VitD intervention group were lower than those of the asthma model group (P<0.05), which were consistent with the result of heatmap analysis based on genera level. Conclusion VitD intervention can regulate the balance of peripheral blood T lymphocytes and change the intestinal flora of young mice with asthma, which may be a new entry point for the pathogenesis of this disease.
Key wordsVitamin D    Bronchial asthma    Intestinal flora    Peripheral blood T lymphocyte homeostasis    Regulation mechanism
    
基金资助:浙江省医药卫生科技计划项目(2022ZH043);
浙江省杭州市萧山区重大科技计划项目(2020301)。
通讯作者: ▲通讯作者   
引用本文:   
蔡姿秀1  周国华1  田军2▲. 维生素D干预对支气管哮喘幼鼠外周血T淋巴细胞平衡调节及肠道菌群的影响[J]. 中国医药导报, 2023, 20(16): 21-25,36.
CAI Zixiu1 ZHOU Guohua1 TIAN Jun2▲. Effects of vitamin D intervention on balance regulation of peripheral blood T lymphocytes and intestinal flora in young rats with bronchial asthma. 中国医药导报, 2023, 20(16): 21-25,36.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.16.04     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I16/21

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司